Complementary and alternative medicine use among patients with thoracic malignancies

Supportive Care in Cancer

Volumn 22, Issue 7, 2014, Pages 1857-1866

  Bismark, Rashmi S ^a,b   Chen, Hongbin ^a   Dy, Grace K ^a   Gage Bouchard, Elizabeth A ^b   Mahoney, Martin C ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Complementary therapies ; Cross sectional studies; Lung neoplasms complications ; therapy; utilization

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CHINESE MEDICINE; CHIROPRACTIC; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MASSAGE; MEDITATION; MESOTHELIOMA; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; THORAX CANCER; TREATMENT OUTCOME; VERY ELDERLY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOTIVATION; MULTIVARIATE ANALYSIS; ODDS RATIO; SELF REPORT; THORACIC NEOPLASMS; UNITED STATES;

EID: 84902368828     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2144-0     Document Type: Article

References (51)

1. WHO (2008) Cancer Fact Sheets. http://www.who.int/mediacentre/factsheets/ fs297/en/. Accessed 21 Dec 2011
2. NCI (2011) SEER Stat Fact Sheets. http://seer.cancer.gov/statfacts/html/ lungb.html. Accessed 25 March 2013
3. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11-30. doi:10.3322/caac.21166
4. Degner LF, Sloan JA (1995) Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manag 10(6):423-431
5. Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD (2007) Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 55(2):215-224. doi:10.1016/j.lungcan.2006.10.001 (Pubitemid 46084946)
6. Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8(5):953-961. doi:10.1089/jpm.2005.8.953 (Pubitemid 41579237)
7. Kristoffersen AE, Fonnebo V, Norheim AJ (2009) Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others? J Altern Complement Med 15(1):35-40. doi: 10.1089/acm.2008.0262
8. NCCAM (2008) What is complementary and alternative medicine? [NCCAM CAM Basics]. http://nccam.nih.gov/health/whatiscam/. Accessed 21 Dec 2011
9. Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85-120
10. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports (12):1-23
11. Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv Res Pract 5(1):8-17. doi:10.1007/s11764-010-0153-7
12. Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N ZMed J 116(1168):U296
13. Ezeome ER, Anarado AN (2007) Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Alternat Med 7:28. doi:10.1186/1472-6882-7-28
14. Harris P, Finlay IG, Cook A, Thomas KJ, Hood K (2003) Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complement Ther Med 11(4): 249-253 (Pubitemid 38292337)
15. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S (2005) Nationwide survey on complementary and alternativemedicine in cancer patients in Japan. J Clin Oncol Off J Am Soc Clin Oncol 23(12):2645-2654. doi:10.1200/JCO.2005.04.126 (Pubitemid 46179453)
16. Pud D, Kaner E, Morag A, Ben-Ami S, Yaffe A (2005) Use of complementary and alternative medicine among cancer patients in Israel. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 9(2):124-130. doi:10.1016/j.ejon.2005.03.011 (Pubitemid 40790433)
17. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol Off J Am Soc Clin Oncol 18(13):2505-2514 (Pubitemid 30432515)
18. Boehmer L, Waqar S, Butler S, Sezhiyan A, Govindan R (2011) Summary of presentations from the 46th annual meeting of the American Society of Clinical Oncology (2010): focus on supportive care issues related to lung cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 6(3):645 - 649. doi :10.1097/JTO.0b013e318200f95d
19. Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, Pietanza MC, Cassileth BR (2013) Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e420S-e436S. doi:10.1378/chest.12-2364
20. Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E, Browall M, Fernandez-Ortega P, Pud D, Margulies A (2006) Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 12(1):34-39. doi:10.1016/j.ctcp.2005.09.007 (Pubitemid 43056766)
21. Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R (2010) Complementary and alternative medicine in lung cancer patients: a neglected phenomenon? Front Radiat Ther Oncol 42:198-205. doi: 10.1159/000262477
22. Lovgren M, Wilde-Larsson B, Hok J, Levealahti H, Tishelman C (2011) Push or pull? Relationships between lung cancer patients' perceptions of quality of care and use of complementary and alternative medicine. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 15(4): 311-317. doi:10.1016/j.ejon.2010.10.004
23. Wells M, Sarna L, Cooley ME, Brown JK, Chernecky C, Williams RD, Padilla G, Danao LL (2007) Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs 30(1):45-55, quiz 56-47
24. Mosher CE, Hanna N, Jalal SI, Fakiris AJ, Einhorn LH, Birdas TJ, Kesler KA, Champion VL (2013) Support service use and interest in support services among lung cancer patients. Lung Cancer 82(1): 162-167. doi:10.1016/j.lungcan. 2013.06.020
25. Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R (2011) Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer 117(22):5142-5150. doi:10.1002/cncr.26164
26. McCarty RL, Weber WJ, Loots B, Breuner CC, Vander Stoep A, Manhart L, Pihoker C (2010) Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med 16(2):165-173. doi:10.1089/acm.2008.0566
27. Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA (2004) Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol Off J Am Soc Clin Oncol 22(23):4810-4815. doi:10.1200/JCO.2004.03.121
28. Gansler T, Kaw C, Crammer C, Smith T (2008) A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer 113(5):1048-1057. doi:10.1002/cncr.23659
29. Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11(1):42-49 (Pubitemid 40110627)
30. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S (2012) Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist 17(11):1475-1481. doi:10.1634/theoncologist.2012-0223
31. Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat 100(2):219-227. doi: 10.1007/s10549-006-9239-3 (Pubitemid 44631924)
32. McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD (2012) Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(1):65-73. doi:10.1007/s00520-010-1055-y
33. Klafke N, Eliott JA, Wittert GA, Olver IN (2012) Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Ann Oncol: Off J Eur Soc Med Oncol/ESMO 23(6):1571-1578. doi:10.1093/annonc/mdr521
34. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Advance data (343):1-19
35. Hedderson MM, Patterson RE, Neuhouser ML, Schwartz SM, Bowen DJ, Standish LJ, Marshall LM (2004) Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med 10(5):58-64 (Pubitemid 39295854)
36. Kristoffersen AE, Norheim AJ, Fonnebo VM (2013) Complementary and alternative medicine use among Norwegian cancer survivors: gender-specific prevalence and associations for use. Evid Based Complement Alternat Med: eCAM 2013:318781. doi:10.1155/2013/318781
37. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340 (22) :1733-1739. doi:10.1056/NEJM199906033402206 (Pubitemid 29252602)
38. Stein KD, Kaw C, Crammer C, Gansler T (2009) The role of psychological functioning in the use of complementary and alternative-methods among disease-free colorectal cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer 115(18 Suppl):4397-4408. doi:10.1002/cncr.24591
39. Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I (2007) Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 16(2): 144-149. doi:10.1111/j.1365- 2354.2006.00722.x
40. Davidson R, Geoghegan L, McLaughlin L, Woodward R (2005) Psychological characteristics of cancer patients who use complementary therapies. Psycho-Oncology 14(3):187-195. doi:10.1002/pon.834 (Pubitemid 40403149)
41. Hamilton AS, Miller MF, Arora NK, Bellizzi KM, Rowland JH (2012) Predictors of use of complementary and alternative medicine by non-Hodgkin lymphoma survivors and relationship to quality of life. Integr Cancer Ther. doi:10.1177/1534735412449733
42. Henderson JW, Donatelle RJ (2003) The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-Oncology 12(1):59-67. doi:10.1002/pon.636 (Pubitemid 36168001)
43. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89(4):873-880 (Pubitemid 30658588)
44. Mao JJ, Palmer SC, Straton JB, Cronholm PF, Keddem S, Knott K, Bowman MA, Barg FK (2008) Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. J Cancer Surviv Res Pract 2(2):116-124. doi:10.1007/s11764-008-0052-3
45. Elkins G, Fisher W, Johnson A (2010) Mind-body therapies in integrative oncology. Curr Treat Options in Oncol 11(3-4):128-140. doi:10.1007/s11864-010- 0129-x
46. Shennan C, Payne S, Fenlon D (2011) What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psycho-Oncology 20(7):681-697. doi:10.1002/pon.1819
47. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL (2013) Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 105(16):1230-1238. doi:10.1093/jnci/djt181
48. Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E (2011) Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop. Oncologist 16(12):1800-1805. doi:10.1634/theoncologist.2011-0252
49. Geffen JR (2010) Integrative oncology for the whole person: a multidimensional approach to cancer care. Integr Cancer Ther 9(1): 105-121. doi:10.1177/1534735409355172
50. Maizes V, Rakel D, Niemiec C (2009) Integrative medicine and patient-centered care. Explore (NY) 5(5):277-289. doi:10.1016/j.explore.2009.06. 008
51. Ernst E (2010) Complementary therapies for supportive cancer care. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 18(11):1365-1366. doi:10.1007/s00520-010-0991-x